Literature DB >> 27226794

Until Death Do Us Part: Necrosis and Oxidation Promote the Tumor Microenvironment.

Ramin Lotfi1, Christof Kaltenmeier2, Michael T Lotze2, Christoph Bergmann3.   

Abstract

Tumor proliferation is concomitant with autophagy, limited apoptosis, and resultant necrosis. Necrosis is associated with the release of damage-associated molecular pattern molecules (DAMPs), which act as 'danger signals', recruiting inflammatory cells, inducing immune responses, and promoting wound healing. Most of the current treatment strategies for cancer (chemotherapy, radiation therapy, hormonal therapy) promote DAMP release following therapy-induced tumor death by necroptosis and necrosis. Myeloid cells (monocytes, dendritic cells (DCs), and granulocytes), as well as mesenchymal stromal cells (MSCs) belong to the early immigrants in response to unscheduled cell death, initiating and modulating the subsequent inflammatory response. Responding to DAMPs, MSCs, and DCs promote an immunosuppressive milieu, while eosinophils induce oxidative conditions limiting the biologic activity of DAMPs over time and distance. Regulatory T cells are strongly affected by pattern recognition receptor signaling in the tumor microenvironment and limit immune reactivity coordinately with myeloid-derived suppressor cells. Means to 'aerobically' oxidize DAMPs provide a novel strategy for limiting tumor progression. The present article summarizes our current understanding of the impact of necrosis on the tumor microenvironment and the influence of oxidative conditions found within this setting.

Entities:  

Year:  2016        PMID: 27226794      PMCID: PMC4872058          DOI: 10.1159/000444941

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  204 in total

1.  High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21-Mediated Matrix Metalloproteinase Activity.

Authors:  Man Chen; Yao Liu; Patrick Varley; Ying Chang; Xing-Xing He; Hai Huang; Daolin Tang; Michael T Lotze; Jusheng Lin; Allan Tsung
Journal:  Cancer Res       Date:  2015-02-26       Impact factor: 12.701

2.  S100A4 and uric acid promote mesenchymal stromal cell induction of IL-10+/IDO+ lymphocytes.

Authors:  Judith Luiza Eisenbacher; Hubert Schrezenmeier; Bernd Jahrsdörfer; Christof Kaltenmeier; Markus Thomas Rojewski; Tatjana Yildiz; Thamara Beyer; Alexander Erle; Denis Sebastian Wiegmann; Stefan Grassl; Regina Hang; Sixten Körper; Markus Wiesneth; Michael T Lotze; Ramin Lotfi
Journal:  J Immunol       Date:  2014-05-02       Impact factor: 5.422

3.  Regulation of glutathione levels in mouse spleen lymphocytes by transport of cysteine.

Authors:  T Ishii; Y Sugita; S Bannai
Journal:  J Cell Physiol       Date:  1987-11       Impact factor: 6.384

Review 4.  NK cells: innate immunity against hematological malignancies?

Authors:  Régis T Costello; Cyril Fauriat; Simona Sivori; Emanuela Marcenaro; Daniel Olive
Journal:  Trends Immunol       Date:  2004-06       Impact factor: 16.687

5.  Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance.

Authors:  Xuefang Cao; Sheng F Cai; Todd A Fehniger; Jiling Song; Lynne I Collins; David R Piwnica-Worms; Timothy J Ley
Journal:  Immunity       Date:  2007-10-04       Impact factor: 31.745

Review 6.  Molecular basis of metastasis.

Authors:  Anne C Chiang; Joan Massagué
Journal:  N Engl J Med       Date:  2008-12-25       Impact factor: 91.245

7.  In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2.

Authors:  M T Lotze; L W Frana; S O Sharrow; R J Robb; S A Rosenberg
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

Review 8.  The tumor microenvironment and its role in promoting tumor growth.

Authors:  T L Whiteside
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

Review 9.  Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination.

Authors:  Fabian Benencia; Leslee Sprague; John McGinty; Michelle Pate; Maria Muccioli
Journal:  J Biomed Biotechnol       Date:  2012-03-15

10.  Extracellular redox modulation by regulatory T cells.

Authors:  Zhonghua Yan; Sanjay K Garg; Jonathan Kipnis; Ruma Banerjee
Journal:  Nat Chem Biol       Date:  2009-08-30       Impact factor: 15.040

View more
  10 in total

1.  A Tumor Cell-Selective Inhibitor of Mitogen-Activated Protein Kinase Phosphatases Sensitizes Breast Cancer Cells to Lymphokine-Activated Killer Cell Activity.

Authors:  Christof T Kaltenmeier; Laura L Vollmer; Lawrence A Vernetti; Lindsay Caprio; Keanu Davis; Vasiliy N Korotchenko; Billy W Day; Michael Tsang; Keren I Hulkower; Michael T Lotze; Andreas Vogt
Journal:  J Pharmacol Exp Ther       Date:  2017-02-02       Impact factor: 4.030

Review 2.  Making cold malignant pleural effusions hot: driving novel immunotherapies.

Authors:  Pranav Murthy; Chigozirim N Ekeke; Kira L Russell; Samuel C Butler; Yue Wang; James D Luketich; Adam C Soloff; Rajeev Dhupar; Michael T Lotze
Journal:  Oncoimmunology       Date:  2019-01-22       Impact factor: 8.110

3.  Innate Immune System for Diagnostics and Therapy: Progress in Fundamental Knowledge and Clinical Application.

Authors:  Julia Kzhyshkowska; Peter Bugert
Journal:  Transfus Med Hemother       Date:  2016-03-31       Impact factor: 3.747

Review 4.  Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells.

Authors:  Catharina Melzer; Juliane von der Ohe; Hendrik Lehnert; Hendrik Ungefroren; Ralf Hass
Journal:  Mol Cancer       Date:  2017-02-01       Impact factor: 27.401

5.  Improved Multimodal Tumor Necrosis Imaging with IRDye800CW-DOTA Conjugated to an Albumin-Binding Domain.

Authors:  Marcus C M Stroet; Erik de Blois; Marion de Jong; Yann Seimbille; Laura Mezzanotte; Clemens W G M Löwik; Kranthi M Panth
Journal:  Cancers (Basel)       Date:  2022-02-09       Impact factor: 6.639

6.  The percentage of peripheral eosinophils as a sensitive marker for differentiating FIGO grade in endometrial adenocarcinomas

Authors:  Serkan Akış; Uğur Kemal Öztürk; Esra Keleş; Cihat Murat Alınca; Murat Api; Canan Kabaca
Journal:  J Turk Ger Gynecol Assoc       Date:  2022-03-10

Review 7.  AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer.

Authors:  E Jensen-Jarolim; H J Bax; R Bianchini; S Crescioli; T R Daniels-Wells; D Dombrowicz; E Fiebiger; H J Gould; S Irshad; J Janda; D H Josephs; F Levi-Schaffer; L O'Mahony; G Pellizzari; M L Penichet; F Redegeld; F Roth-Walter; J Singer; E Untersmayr; L Vangelista; S N Karagiannis
Journal:  Allergy       Date:  2017-10-05       Impact factor: 13.146

8.  Intrapulmonic Cavity or Necrosis on Baseline CT Scan Serves as an Efficacy Predictor of Anti-PD-(L)1 Inhibitor in Advanced Lung Squamous Cell Carcinoma.

Authors:  Tao Lu; Longfeng Zhang; Mingqiu Chen; Xiaobin Zheng; Kan Jiang; Xinlong Zheng; Chao Li; Weijin Xiao; Qian Miao; Shanshan Yang; Gen Lin
Journal:  Cancer Manag Res       Date:  2021-07-30       Impact factor: 3.989

Review 9.  The Role of Inflammation in Breast and Prostate Cancer Metastasis to Bone.

Authors:  Andy Göbel; Stefania Dell'Endice; Nikolai Jaschke; Sophie Pählig; Amna Shahid; Lorenz C Hofbauer; Tilman D Rachner
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

10.  Prediction of the efficacy of immunotherapy by measuring the integrity of cell-free DNA in plasma in colorectal cancer.

Authors:  Masahiro Kitahara; Shoichi Hazama; Ryouichi Tsunedomi; Hiroko Takenouchi; Shinsuke Kanekiyo; Yuka Inoue; Masao Nakajima; Shinobu Tomochika; Yoshihiro Tokuhisa; Michihisa Iida; Kazuhiko Sakamoto; Nobuaki Suzuki; Shigeru Takeda; Tomio Ueno; Shigeru Yamamoto; Shigefumi Yoshino; Hiroaki Nagano
Journal:  Cancer Sci       Date:  2016-12-18       Impact factor: 6.716

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.